Effects of 5-Amino Salicylic Acid on the Expression of Multidrug Resistance Gene in Ulcerative Colitis

被引:3
|
作者
Zhang, Ying-Jian [1 ]
Wang, Ping [2 ]
Zhang, Yu [1 ]
Zheng, Yu-Feng [1 ]
Jin, Jian-Jun [1 ]
Wang, Jin-Liang [1 ]
机构
[1] Henan Univ Sci & Technol, Dept Gastroenterol, Affiliated Hosp 1, Luoyang 471000, Peoples R China
[2] Henan Univ Sci & Technol, Dept Prevent Med, Coll Med, Luoyang 471000, Peoples R China
关键词
P-glycoprotein; colitis; ulcerative; gene expression; resistance; multiple drug; gene; INFLAMMATORY-BOWEL-DISEASE; ABCB1; MDR1; POLYMORPHISMS; REMISSION; ALPHA;
D O I
10.5754/hge121341
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: To study the effect of drugs on the expression of multidrug resistance gene in ulcerative. colitis. Methodology: The expressions of multidrug resistance (MDR) 1 gene and its product P-Gp were detected by reverse transcription-polymerase chain reaction and immunohistochemistry to realize the impact of drugs on ulcerative colitis. Results: MDR1 gene and P-Gp did not exhibit significant difference (P >0.05) before and after amino salicylic acid drug treatment. Compared with the control group, their expressions before treatment in the ineffective corticosteroid- and immunosuppressant-treated groups did not exhibit significant difference (P >0.05). Their pre- and post-treatment expressions in the ineffective groups were compared with those in the normal control group and in the effective group, and significant differences were observed (P <0.05). Conclusions: 5-Amino salicylic acid drugs have little effect on the expression of MDR1 and its product P-Gp. The expressions of MDR1 and P-Gp were much higher in groups that showed ineffectiveness for corticosteroids and immunosuppressants after treatment.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 50 条
  • [1] Comparison of 5-amino salicylic acid plus glucocorticosteroid with metronidazole and ciprofloxacin in patients with active ulcerative colitis
    Parlak, E
    Dagli, U
    Ülker, A
    Alkim, C
    Sahim, B
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (01) : 85 - 86
  • [2] ORAL 5-AMINO SALICYLIC-ACID FOR THE MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS - A CONTROLLED TRIAL
    DEW, MJ
    HUGHES, PJ
    HARRIES, AD
    WILLIAMS, G
    EVANS, BK
    RHODES, J
    GUT, 1982, 23 (10) : A892 - A892
  • [3] COLONIC RELEASE OF 5-AMINO SALICYLIC-ACID FROM AN ORAL PREPARATION IN ACTIVE ULCERATIVE-COLITIS
    DEW, MJ
    RYDER, REJ
    EVANS, N
    EVANS, BK
    RHODES, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) : 185 - 187
  • [4] MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS WITH 5-AMINO SALICYLIC-ACID IN HIGH-DOSES BY MOUTH
    DEW, MJ
    HARRIES, AD
    EVANS, N
    EVANS, BK
    RHODES, J
    BRITISH MEDICAL JOURNAL, 1983, 287 (6384): : 23 - 24
  • [5] 5-Amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine
    Stretch, GL
    Campbell, BJ
    Dwarakanath, AD
    Yaqoob, M
    Stevenson, A
    Morris, AI
    Rhodes, JM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (06) : 941 - 947
  • [6] EFFECT OF POLYMER COATING ON FECAL RECOVERY OF INGESTED 5-AMINO SALICYLIC-ACID IN PATIENTS WITH ULCERATIVE-COLITIS
    ALMARDINI, H
    LINDSAY, DC
    DEIGHTON, CM
    RECORD, CO
    GUT, 1987, 28 (09) : 1084 - 1089
  • [7] EFFECT OF POLYMER COATING ON FECAL RECOVERY OF INGESTED 5-AMINO SALICYLIC-ACID IN PATIENTS WITH ULCERATIVE-COLITIS
    BJARNASON, I
    MIDDLETON, K
    GUT, 1988, 29 (03) : 413 - 413
  • [8] MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS WITH AN ORAL PREPARATION OF 5-AMINO SALICYLIC-ACID IN HIGH-DOSES
    DEW, MJ
    HARRIES, AD
    EVANS, N
    EVANS, BK
    RHODES, J
    GUT, 1983, 24 (10) : A983 - A983
  • [9] 5-AMINO SALICYLIC-ACID (5-ASA) ENEMAS IN THE TREATMENT OF ACUTE ULCERATIVE-COLITIS - A CONTROLLED-STUDY
    PONTES, EL
    LEMME, EMO
    PORTO, JAF
    ZALTMAN, C
    DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) : S381 - S381
  • [10] Anti-inflammatory effects of acacia and guar gum in 5-amino salicylic acid formulations in experimental colitis
    Jhundoo, Henusha D.
    Siefen, Tobias
    Liang, Alfred
    Schmidt, Christoph
    Lokhnauth, John
    Moulari, Brice
    Beduneau, Arnaud
    Pellequer, Yann
    Larsen, Crilles Casper
    Lamprecht, Alf
    INTERNATIONAL JOURNAL OF PHARMACEUTICS-X, 2021, 3